Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Norton CFC-free beclomethasone inhaler U.K. approval could come this year following patent victory.

Executive Summary

NORTON ANTICIPATES CFC-FREE BECLOMETHASONE INHALER U.K. APPROVAL IN LATE 1997 following a recent victory over 3M in the British patent courts. The U.K. court invalidated three European patents held by 3M which relate to the use of the CFC-free propellant P134a in metered dose inhalers. The ruling clears the way for Ivax' U.K. subsidiary Norton Healthcare to market its CFC-free beclomethasone inhaler in Great Britain once the product is approved by the Medicines Control Agency. Norton is predicting a U.K. launch in early 1998.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030558

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel